{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P00797",
      "entity_text" : "renin",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5493444",
      "entity_text" : "aliskiren",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "An additional intervention is the renin blocker aliskiren, which when given in addition to ARBs caused in the Aliskiren in the Evaluation of Proteinuria in Diabetes (AVOID) study significant further reduction of albuminuria in type 2 diabetic patients.",
  "reading_complete" : "2020-07-28T15:14:46Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T15:13:40Z",
  "trigger" : "blocker",
  "evidence" : [ "renin blocker aliskiren" ],
  "pmc_id" : "3632202",
  "score" : 0
}